000			00977 a2200277 4500
005			20250513100938.0
264		0	_c19961129
008			199611s 0 0 eng d
022			_a0037-1963
040			_aNLM _beng _cNLM
100	1		_aPark, D J
245	0	0	_aTherapy-related myelodysplastic syndromes. _h[electronic resource]
260			_bSeminars in hematology _cJul 1996
300			_a256-73 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review
650	0	4	_aAntineoplastic Agents _xadverse effects
650	0	4	_aHumans
650	0	4	_aKaryotyping
650	0	4	_aLeukemia, Myeloid, Acute _xchemically induced
650	0	4	_aLymphoma _xdrug therapy
650	0	4	_aMyelodysplastic Syndromes _xchemically induced
650	0	4	_aNeoplasms _xdrug therapy
650	0	4	_aRisk Factors
700	1		_aKoeffler, H P
773	0		_tSeminars in hematology _gvol. 33 _gno. 3 _gp. 256-73
999			_c8813496 _d8813496